Yousif Capital Management LLC Lowers Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Yousif Capital Management reduced its stake in Intuitive Surgical by 5.4% in Q4, selling 2,747 shares and leaving it with 47,740 shares valued at about $25.18 million.
• Intuitive Surgical beat Q4 expectations with EPS of $2.53 (vs. $2.27 expected) and revenue of $2.87 billion (vs. $2.72 billion expected), with revenue up 18.8% year-over-year.
• Corporate insiders have sold 32,943 shares worth $17.28 million over the past 90 days, institutional investors own 83.64% of the stock, and analysts hold a consensus rating of Moderate Buy with an average price target of $611.77.

Yousif Capital Management LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,740 shares of the medical equipment provider's stock after selling 2,747 shares during the period. Yousif Capital Management LLC's holdings in Intuitive Surgical were worth $25,180,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 33 shares during the period. Holos Integrated Wealth LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $28,000. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at about $27,000. Finally, Caitlin John LLC purchased a new stake in Intuitive Surgical during the third quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $452.95 on Wednesday. The stock's 50-day moving average is $484.46 and its two-hundred day moving average is $514.43. The stock has a market cap of $160.86 billion, a PE ratio of 57.41, a P/E/G ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts' expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm's quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.21 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the business's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 32,943 shares of company stock valued at $17,279,568 over the last 90 days. Corporate insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Weiss Ratings reissued a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Truist Financial boosted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the company a "buy" rating in a research report on Thursday, December 18th. Wall Street Zen downgraded Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. The Goldman Sachs Group reissued a "buy" rating and set a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, Sanford C. Bernstein boosted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an "outperform" rating in a research report on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $611.77.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.